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Abstract
The extended amygdala has dominated research on the neural circuitry of fear and anxiety, but the
septo-hippocampal axis plays an important role as well. The lateral septum (LS) is thought to
suppress fear and anxiety, through its outputs to the hypothalamus. However, this structure has not
yet been dissected using modern tools. The type 2 CRF receptor (Crfr2) marks a subset of LS
neurons, whose functional connectivity we have investigated using optogenetics. Crfr2+ cells
include GABAergic projection neurons that connect with the anterior hypothalamus. Surprisingly,
we find that these LS outputs enhance stress-induced behavioral measures of anxiety.
Furthermore, transient activation of Crfr2+ neurons promotes, while inhibition suppresses,
persistent anxious behaviors. LS Crfr2+ outputs also positively regulate circulating corticosteroid
levels. These data identify a subset of LS projection neurons that promote, rather than suppress,
stress-induced behavioral and endocrinological dimensions of persistent anxiety states, and
provide a cellular point-of-entry to LS circuitry.
INTRODUCTION
Stress is an etiologic factor in psychiatric disorders, especially those involving anxiety
(Gross and Hen, 2004; Feder et al., 2009; Lupien et al., 2009). Consequently, considerable
effort has been made to map the neural circuits through which stress promotes anxiety, most
recently using optogenetic tools (Nieh et al., 2012; Tye and Deisseroth, 2012). The majority
of such studies have focused on the extended amygdala (EA)(Davis et al., 2010; Tye et al.,
2011; Mahan and Ressler, 2012; Jennings et al., 2013; Kim et al., 2013). The septo-
hippocampal axis (SHA) has also been implicated (Gray and McNaughton, 2000), but has
received less attention in the modern era. Several studies have indicated a role for the ventral
hippocampus in anxiety (Henke, 1990; Kjelstrup et al., 2002; Felix-Ortiz et al., 2013;
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Kheirbek et al., 2013). However, the lateral septum (LS), a major component of the SHA
(Fig. 1B), has been relatively neglected in comparison to the intense focus on the EA.
The LS receives topographically organized inputs from the hippocampus (Risold and
Swanson, 1996) and is in turn reciprocally connected with the hypothalamus (Risold and
Swanson, 1997b) (Fig. 1A). It is also cellularly heterogeneous (Risold and Swanson, 1997a).
A variety of stressors induce immediate early gene (IEG) expression in subsets of LS
neurons (reviewed in (Sheehan et al., 2004)). Furtherore, traumatic stress triggers a
persistent enhancement of LS IEG induction in response to innately aversive stimuli
(Mongeau et al., 2003). Importantly, whether such stress-induced activation of the LS serves
to promote, or rather to inhibit, persistent anxiety states is not clear.
Classical lesions of the septum, including both its medial and lateral subdivisions, resulted in
the dramatic ‘septal rage’ phenotype, characterized by exaggerated defensive responses to
non-threatening stimuli (Spiegel et al., 1940; Brady and Nauta, 1953). Reversible
inactivation of the LS yielded similar phenotypes (Albert and Richmond, 1976; Albert and
Wong, 1978). These and other data have led to a prevailing view that LS output is
anxiolytic, i.e., dampens fear or anxiety (reviewed in (Sparks and LeDoux, 2000; Sheehan et
al., 2004)).
Other studies, however, have implied an anxiogenic role for the LS (Drugan et al., 1986;
Treit and Pesold, 1990). For example, LS injections of agonists of the type 2 corticotropin-
releasing factor receptor (Crfr2) have resulted in increased anxiety (Radulovic et al., 1999;
Bakshi et al., 2002; Henry et al., 2006). However, it is not clear whether such agonists excite
or inhibit the neurons that express these receptors (Liu et al., 2004; Liu et al., 2005). Indeed,
Crfr2 mutations increase anxiety, implying an anxiolytic function for the receptor (Bale and
Vale, 2004). These ambiguities, together with the unknown anatomy and connectivity of
Crfr2+ neurons, preclude any inferences of functional LS circuitry to be made from such
pharmacologic and genetic data (Fig. 1C, D).
As an initial step towards dissecting the circuitry through which the LS regulates anxiety, we
have gained genetic access to Crfr2-expressing neurons, and have used optogenetics,
electrophysiology and anatomical mapping to understand how the electrical activity of these
neurons influences anxiety, and the connectivity through which this influence is exerted. We
find, contrary to the prevailing view, that Crfr2 marks LS output neurons whose activity
promotes, rather than inhibits, anxiety, in a persistent manner. Thus LS output does not
serve exclusively to suppress fear or anxiety in response to stressors (Sheehan et al., 2004).
RESULTS
Crfr2 expression identifies a subset of GABAergic LS neurons
In situ hybridization (ISH) revealed that Crfr2 mRNA is expressed by a subset of LS cells
(Figs. 2A–E). Double fluorescence ISH (dFISH) revealed that most Crfr2+ cells express the
GABA biosynthetic gene Gad2 (1,765/2,076 = 85.0%; Fig. 2F), whereas no overlap was
detected with either glutamatergic or cholinergic markers (Fig. S1), indicating that Crfr2 is
expressed primarily by GABAergic neurons. Comparison of Crfr2 mRNA to that of Esr1 or
Penk, two genes heterogeneously expressed in the LS (Risold and Swanson, 1997a)
indicated little or no overlap at the single cell level: Crfr2 vs. Esr1, Crfr2+/DAPI+ = 8.3%,
Esr1+/DAPI+ = 1.7%; 8.3%×1.7%×11,086 cells counted = 15 Crfr2+Esr1+ cells expected if
expression were random; 0 Crfr2+Esr1+ cells were observed; Crfr2 vs. Penk, Crfr2+/DAPI+
= 9.3%, Penk+/DAPI+ = 3.3%; 9.3%×3.3%×8,274 cells counted = 25 Crfr2+/Penk+ cells
expected if expression were random; 1 Crfr2+Penk+ cell was observed (Figs. 2G–J). These
Anthony et al. Page 2
Cell. Author manuscript; available in PMC 2015 January 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
data indicate that Crfr2+ neurons are distinct from other molecularly defined populations of
LS cells.
To enable genetic manipulation of Crfr2+ neurons, we generated BAC (bacterial artificial
chromosome) transgenic mice expressing an eGFPCre fusion protein (Gagneten et al.,
1997)) under the control of the brain-selective alpha splice variant of the Crfr2 gene (Fig.
2K). Comparison by dFISH of eGFPCre expression to that of endogenous Crfr2 mRNA
indicated that 86.6% of Cre+ cells contained Crfr2 mRNA; conversely, 34.4% of Crfr2
mRNA+ cells were Cre+ (Figs. 2L,M). This indicates that the BAC transgene is highly
specific for Crfr2+ neurons, but may be expressed in a subset of such cells. Immunostaining
revealed that many eGFPCre+ cells are surrounded by pericellular baskets containing UCN3,
a CRFR2 peptide ligand (Figs. 2N,O), suggesting that these cells respond to this ligand in
vivo.
To examine Cre-mediated recombination in Crfr2α-eGFPCre mice, the LS was injected
with a Cre-dependent (FLEx) adeno-associated virus (AAV) encoding membrane-targeted
tdTomato reporter (channelrhodopsin-2 (ChR2)-tdTomato(tdT) fusion) (Atasoy et al., 2008)
(Fig. 2P). Almost 80% (77.9%) of tdT+ cells contained detectable eGFPCre+ nuclei (Figs.
2Q,R). The presence of tdT in some eGFPCre− cells may reflect low and/or transient
expression of Cre, coupled with the high sensitivity and perdurance of fluorescent marker
expression, as observed in other Cre driver lines (Madisen et al., 2010). In support of this
idea, dFISH showed that 91.6% of tdT mRNA+ cells were Crfr2 mRNA+ (Figs. 2S,T).
Importantly, recombination did not occur in ESR1+ or Penk+ LS neurons (Fig. S2). Thus,
the Crfr2α-eGFPCre BAC transgene restricts recombination of injected Cre-dependent
viruses to LS Crfr2+ neurons.
Optogenetic activation of Crfr2α+ neurons is anxiogenic
The valence of LS Crfr2α+ neuronal activity with respect to anxiety is unclear. Although
infusions of CRFR2 receptor agonists into LS have consistently yielded anxiogenic effects
(Radulovic et al., 1999; Bakshi et al., 2002; Henry et al., 2006; Bakshi et al., 2007), slice
recordings showed that receptor activation can both inhibit (Liu et al., 2004) and potentiate
(Liu et al., 2005) neuronal activity. Consequently, it is unknown whether CRFR2 receptor
activation increases anxiety through a decrease or an increase in Crfr2α+ neuronal activity
(Figs. 1C,D). Therefore we tested whether direct activation of Crfr2α-expressing neurons
increases or decreases anxiety.
To do this, we targeted a Channelrhodopsin-2-yellow fluorescent protein fusion (ChR2-
YFP) to Crfr2α+ neurons by injecting a Cre-dependent AAV (Fig. 3A) into the LS of
Crfr2α-eGFPCre mice. ChR2-YFP was spatially correlated with Cre expression and
restricted to the LS, with no ChR2-YFP+ cell bodies detected outside of this region (Figs.
3B–E and data not shown). Slice recordings revealed that ChR2-YFP+ neurons could be
efficiently and repetitively photostimulated at rates up to 15 Hz (Figs. 3F–H and Figs. S3A–
C). Although LS Crfr2α+ neuron in vivo firing rates are unknown, single unit recordings in
the LS have observed spike frequencies as high as 26 Hz (Thomas et al., 2005).
Furthermore, LS recordings during elevated plus maze (EPM) tests identified units whose
activity increased from ~7.5 Hz in the closed arms to ~12.5 Hz in the open arms (Thomas et
al., 2013). We therefore chose a photostimulation rate of 15 Hz, which is in the range of
natural firing rates of LS neurons in anxiogenic environments.
Three behavioral tests of anxiety were used: light-dark box (LDB), open field (OF), and
novel object (NO)(Figs. 3I,J); these tests were chosen as pharmacological experiments
showed them to be sensitive to modulation of LS Crfr2+ neuronal function (Henry et al.,
2006). Photostimulation during testing significantly increased anxiety levels in the ChR2
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group in all three assays relative to light-stimulated control animals injected with Cre-
dependent AAV encoding hrGFP (Fig. 3K). Anxiogenic effects were also detected in the
EPM (Fig. S3D). These effects were not due to a change in locomotor activity (Fig. S3E). In
the absence of light, no significant differences were detected (Fig. S3F). Thus, direct
optogenetic stimulation of Crfr2α+ neurons during behavioral testing increases anxiety (Fig.
3N).
Transient activation of Crfr2α+ neurons causes a persistent state of anxiety
One feature of anxiety states is their persistence. Therefore, we tested whether transient
optogenetic stimulation of Crfr2α+ neurons might cause persistent anxiogenic effects.
Pharmacological approaches, such as injection of CRFR2 agonists, cannot address this issue
since once a drug is infused, the duration of its action is unknown.
Mice subjected to 30 minutes of photostimulation were subsequently transferred to a
separate room and behaviorally assayed in the absence of photostimulation (Figs. 3J,L).
ChR2-expressing mice showed increased levels of anxiety relative to eYFP controls
throughout the 35 minute testing period (Fig. 3L) without differences in locomotor behavior
(Fig. S3G). Re-testing of these mice 7 days later in the absence of additional
photostimulation yielded no significant differences in anxiety behavior (Fig. S3H),
indicating that the anxious state induced by Crfr2α+ neuronal stimulation is reversible.
Furthermore, photostimulation at 1 Hz did not produce significant increases in anxiety (Fig.
S3I), suggesting that the persistent effect of activating Crfr2α+ neurons is frequency-
dependent.
The severity of a stressful encounter is thought to influence the degree of its anxiogenic
consequences (Adamec et al., 2006). We therefore asked whether photostimulation of LS
Crfr2α+ neurons can exacerbate the anxiogenic effects of immobilization stress (IMS). Mice
were subjected to IMS for 30′, throughout which time they received photostimulation.
During subsequent testing done in a separate room in the absence of photostimulation, ChR2
mice showed higher levels of anxiety behavior than controls, indicating that stimulation of
LS Crfr2α+ neurons and IMS can combine to exacerbate anxiety (Fig. 3M).
Crfr2α+ neuronal activity is necessary for the induction and expression of a stress-
induced, sensitized state
The foregoing experiments indicated that stimulation of Crfr2α+ neurons is sufficient to
increase anxiety in a persistent manner, but did not address whether the activity of these
neurons is normally required for stress-induced anxiety. In principle, Crfr2α+ neuronal
activity could be necessary for the induction or maintenance (or both) of a persistent anxious
state. To distinguish these possibilities, we injected Crfr2α-eGFPCre mice with a Cre-
dependent AAV (Fig. 4A) encoding yellow fluorescent protein (YFP) fused to the enhanced
halorhodopsin from Natronomonas pharaonis (eNpHR2.0), a light-driven chloride pump that
hyperpolarizes neurons in response to yellow light (Gradinaru et al., 2008). A crescent-
shaped pattern of eNpHR-YFP protein was observed that was restricted to LS and correlated
closely with Cre+ cells (Figs. 4B–E and data not shown). Slice recordings confirmed that
yellow light produced outward currents that hyperpolarized eNpHR-YFP+ neurons without
detectable rebound firing even after prolonged, repeated photoinhibition (Figs. S4A–D), and
that were sufficient to suppress current injection-induced firing (Figs. 4F–H).
To induce an anxious state, mice were subjected to 20′ of IMS after which they were
transferred to the testing room and behaviorally assayed (Figs. 4I,J). To ascertain the
temporal roles of Crfr2α+ neurons, the LS was illuminated with 593nm light either during
IMS or subsequent testing. Photoinhibition of Crfr2α+ neurons produced significant
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anxiolytic effects in eNpHR-injected mice relative to hrGFP controls, regardless of whether
inhibition was done during IMS or testing (Figs. 4L,K). No differences in locomotor
behavior were observed (Figs. S4E,F). In the absence of 593nm light, no differences were
observed between groups (Fig. S4H). Comparisons of light ON vs. OFF periods indicated
that the anxiolytic effects were predominant during illumination, and therefore unlikely to be
due to rebound firing following photoinhibition offset (Fig. S4G).
One caveat was the possibility that the testing environment itself is highly stressful. If so,
then the anxiolytic effects of inhibition during testing (Fig. 4L) might reflect a role for
Crfr2α+ neurons in responding to the stress of the testing conditions, rather than in the
expression of a previously established sensitized state. However, no significant reduction in
anxiety was observed when photoinhibition of Crfr2α+ neurons was done during testing in
mice that had not undergone IMS (Fig. 4M). These data suggest that ongoing activity of
Crfr2α+ neurons is required for both the induction and persistence of a stress-induced
anxious state (Fig. 4N). Taken together, our gain- and loss-of-function data indicate that the
activity of Crfr2α+ neurons exerts a net anxiogenic influence (Fig. 1C).
LS Crfr2α+ GABAergic projections to the anterior hypothalamus mediate persistent stress-
induced anxiety
It is not known whether LS Crfr2α+ neurons are interneurons or projection neurons, nor
have their synaptic targets been identified. Therefore, their anxiogenic influence could
reflect either a local, intra-septal (interneuron) or extra-septal (projection neuron) function
(Fig. 1, C1 vs. C2). To determine whether LS Crfr2α+ neurons have extra-septal projections,
ChR2-YFP was used as an anterograde label (Fig. 5A). Strong somatodendritic labeling of
neurons was observed, as was a robust projection of YFP+ axons coursing ventrally out of
the LS (Figs. 5B–D). The extra-septal region containing the densest cluster of axons was the
anterior hypothalamic area (AHA) of the medial hypothalamus (Figs. 5E,F), with lighter
innervation seen in more rostral and caudal hypothalamic areas, medial amygdala,
periaqueductal gray, and ventral hippocampus (Figures S5A–L). Notably, the
paraventricular nucleus (PVN), which is part of the hypothalamic-pituitary-adrenocortical
(HPA) axis (reviewed in (Ulrich-Lai and Herman, 2009)), appeared to exclude Crfr2α+
axons (Fig. 5G).
To further characterize these putative long range targets of Crfr2α+ neurons, we
iontophoresed cholera toxin subunit B (CTB) into the AHA of Crfr2α-eGFPCre mice (Fig.
5H). At middle coronal levels of LS (bregma+0.6), back labeled neurons formed a crescent
pattern that overlapped with Crfr2α+eGFPCre+ cell bodies (Figs. 5I,J). Moreover, the
overlap of eGFPCre and CTB at the single cell level was significantly higher than that
expected by chance (Fig. 5K). In contrast, significantly fewer Crfr2α+eGFPCre+ neurons
were labeled than that expected by chance when CTB was iontophoresed into the lateral
hypothalamus (LH, a known target of LS innervation (Risold and Swanson, 1997b; Sartor
and Aston-Jones, 2012)), despite similar numbers of back-labeled LS cells (Figs. 5L–O).
These data suggest that Crfr2α-expressing cells at middle levels (bregma+0.6) of LS
preferentially project to AHA vs. LH.
To determine the postsynaptic effects of stimulating Crfr2α+ axons, we employed
Channelrhodopsin-2 (ChR2)-assisted circuit mapping (CRACM) (Petreanu et al., 2007) to
assay postsynaptic responses in AHA neurons near ChR2-YFP+ axons (Fig. 5P). In 6/9 cells
tested, 473nm light evoked picrotoxin-sensitive inhibitory postsynaptic currents (IPSCs)
(average amplitude = 71.3±5.3pA) (Fig. 5Q, top). Responses occurred with a latency of
5.0±0.4 ms, consistent with monosynaptic connectivity (Debanne et al., 2008). Moreover,
photostimulation was sufficient to inhibit spiking in postsynaptic cells (Fig. 5Q, bottom).
Similar results were obtained from local intra-septal targets of Crfr2α+-ChR2-expressing
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neurons in LS slice recordings (Figs. S5M,N). Thus, LS Crfr2α+ projection neurons form
inhibitory synapses with target neurons in the AHA. Neurons in this population also make
local inhibitory synapses within the LS. Whether these local and long-range synapses are
made by the same or different Crfr2α+ neurons is not clear.
The existence of projections to AHA does not in itself establish a role for these connections
in the anxiogenic influence of Crfr2α+ neuronal activity, since it remained possible that such
effects are mediated principally via local intra-septal synapses. To test the requirement of
projections to the AHA for the expression of stress-induced anxiety, we employed the
archaerhodopsin ArchT, a light-driven proton pump that hyperpolarizes neurons in response
to green light and efficiently traffics to axonal termini (Han et al., 2011). Injection of a Cre-
dependent AAV (Fig. 6A) into Crfr2α-eGFPCre LS yielded ArchT expression in a pattern
that correlated with Cre and enabled photoinhibition of cell bodies and axons (Figs. S6B–
M).
Photoinhibition of LS Crfr2α+ terminal fields in the AHA during behavioral testing
following IMS produced significant anxiolytic effects without altering locomotor behavior,
and no significant differences were observed in the absence of 532nm light (Figs. 6B–E and
S6N,O). Conversely, optogenetic stimulation using ChR2-YFP of LS Crfr2α+ axon
terminals in the AHA during testing was anxiogenic in the LDB and OF assays, albeit more
weakly than was observed using LS cell body stimulation (Figs. 6F–J); locomotor behavior
was unaffected (Fig. S6P). Antidromic stimulation of LS cell bodies may contribute to the
behavioral effects of optogenetic terminal activation, but cannot be exclusively responsible
given that photoinhibition of terminals in this region using ArchT was anxiolytic (Fig. 6E).
Together these data suggest that LS Crfr2α+ neurons exert anxiogenic effects, at least in
part, via inhibitory projections to the AHA (Fig. 1C2).
LS Crfr2α+ neurons make di-synaptic connections with PVN via AHA
Despite strong innervation by LS Crfr2α+ axons of the adjacent AHA, the PVN appears
devoid of such projections (Fig. 5G). Given the role of the PVN in the stress response, we
asked whether the PVN might be a higher-order target of LS Crfr2α+ neurons. To test for
evidence of polysynaptic connectivity, we used the herpes simplex virus (HSV) strain
HSV129ΔTK-TT (Fig. 7A), a Cre-dependent transneuronal tracer that moves exclusively in
the anterograde direction (Lo and Anderson, 2011).
At 1 day following delivery of the virus into the LS of Crfr2α-eGFPCre mice, scattered tdT+
cells were observed near the injection site (Fig. 7B) but not in any other region. By 3 days
post-injection, tdT labeling was extensive throughout the LS on the side ipsilateral to
injection (Fig. 7C), and many tdT+ cells were now detectable bilaterally in both the AHA
and PVN (Fig. 7D), consistent with di- or poly-synaptic transfer to the latter structure. Many
tracer-labeled AHA neurons were GABAergic (Fig. S7E–H). The anterogradely labeled
dorsolateral PVN cells were located in a region known to contain parvicellular CRF+
neurons of the mouse PVN that are responsible for initiating the stress responses (Biag et al.,
2012). No tdT fluorescence was detected when HSV129ΔTK-TT was injected into the LS of
nontransgenic animals (data not shown).
To test whether LS Crfr2α+ neurons monosynaptically inhibit AHA neurons that innervate
the PVN, Crfr2α-eGFPCre mice were co-injected in the LS with Cre-dependent ChR2-YFP,
and in the PVN with retrobeads (RB, retrograde tracer) (Figs. 7E,F). Recordings of RB+
cells in the AHA identified 4/9 cells that showed monosynaptic IPSCs in response to a 2ms
pulse of 473nm light (average amplitude = 74.6±33.4pA; average latency = 5.5±0.1 ms) and
that were sufficient to inhibit firing (Fig. 7G). Taken together with the results of the
HSV129ΔTK-TT anterograde tracing, these data demonstrate that LS Crfr2α+ neurons make
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di-synaptic connections to the PVN via their projections to the AHA. Similar experiments
indicated that LS Crfr2α+ neurons also form inhibitory synapses on AHA neurons that
project to the midbrain periaqueductal gray (PAG; Figure S7I–L), a region known to
regulate defensive behaviors relevant to anxiety (Bandler and Shipley, 1994; Almeida-
Santos et al., 2013).
AHA-projecting LS Crfr2α+ neurons positively regulate corticosterone levels
The PVN is innervated by GABAergic AHA neurons implicated in glucocorticoid-induced
negative feedback regulation of HPA axis function (Pacak and Palkovits, 2001; Herman et
al., 2002). Our data suggest that LS Crfr2α+ neurons inhibit GABAergic targets in AHA that
in turn project to PVN. If so, then LS Crfr2+ neurons should exert a net positive-acting
influence on PVN function, via a presumptive di-synaptic disinhibitory connection. To test
this idea, we measured corticosterone (CORT) levels as a surrogate index of PVN activation,
since the PVN positively regulates the HPA axis.
LS Crfr2α+ neurons were optogenetically stimulated for 30 minutes, followed immediately
by blood collection (Fig. 7H). Control experiments indicated that experimental handling,
including anaesthetization, of animals elevates circulating CORT (data not shown), and
baseline CORT was elevated in eYFP control mice, indicating that the HPA axis was
activated under the testing conditions. Nevertheless, optogenetic stimulation yielded
significantly higher levels of CORT in ChR2-injected mice relative to eYFP controls (Fig.
7I).
We next tested whether optogenetic inhibition of LS Crfr2+ terminals in AHA would,
conversely, reduce CORT (Fig. 7J). To maximize CORT levels, mice were subjected to IMS
during photoinhibition. Although CORT levels in IMS-treated controls were similar to those
in non-IMS-treated controls (Figs. 7I vs. K), reflecting the constitutive activation of the
HPA axis under these conditions, optogenetic inhibition yielded a statistically significant
reduction in CORT (Fig. 7K). Together, these gain- and loss-of-function data indicate that
LS Crfr2+ neurons positively modulate CORT levels in the context of an activated HPA
axis. They are, therefore, consistent with the idea that these neurons exert a net positive-
acting influence on PVN function.
DISCUSSION
The LS has long been implicated in the control of stress responses and anxiety, but has not
previously been subjected to functional dissection of its genetically defined constituent
neuronal subpopulations. Here, we have used an optogenetic approach to trace and
functionally manipulate LS Crfr2α+ neurons. We report three major findings regarding their
role in anxiety. First, the valence of LS Crfr2α+ neuronal activation is anxiogenic. Second,
these effects are mediated at least in part via extra-septal projections to the AHA, rather than
by an exclusively intra-septal mechanism. Lastly, transient activation of LS Crfr2α+ neurons
can induce both behavioral and neuroendocrine dimensions of a persistent anxiety state.
Crfr2 marks LS output neurons with an anxiogenic influence
The robust and dramatic ‘septal rage’ phenotype that results from certain electrolytic,
physical, or chemical lesions of the septum (Spiegel et al., 1940; Brady and Nauta, 1953;
Albert and Richmond, 1976) have led to a prevailing view that the output of the LS serves to
dampen fear and anxiety (Sheehan et al., 2004). Anxiogenic cell populations in the LS were,
therefore, inferred to act by providing local inhibition on such anxiolytic output (Henry et
al., 2006). Here we identify a subpopulation of LS output neurons whose activation is
anxiogenic rather than anxiolytic. This anxiogenic influence is exerted, at least in part, via
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long-range inhibitory projections to the medial hypothalamus. These data argue against the
long standing view that LS output serves primarily to suppress fear or anxiety in response to
stressors (Sheehan et al., 2004).
Importantly, we note that our data derive from a transgenic mouse line that drives detectable
Cre expression in a subset of Crfr2 mRNA+ cells. This incomplete expressivity of the
transgene could reflect either stochastic variation, or expression in a deterministic subset of
Crfr2+ neurons due to incomplete capture of the entire transcriptional control region in the
transgene. Whatever the explanation, the fact that complementary gain- and loss-of-function
optogenetic phenotypes were observed argues that the Cre+Crfr2+ subset plays an important
role in the regulation of anxiety. However, our experiments leave open the relationship of
Cre−, Crfr2+ cells to anxiety.
LS Crfr2α+ neurons act via inhibitory projections to the medial hypothalamus
Our optogenetic studies demonstrate that the anxiogenic effects of LS Crfr2α+ neuronal
activity are exerted, at least in part, via GABAergic projections to the medial hypothalamus
(Fig. 1, model 2; Figs. 6E,J). These inhibitory projections exert a positive-acting influence
on both the behavioral and endocrinological dimensions of a stress-induced anxious state.
These effects are mediated at least in part via the inhibition of GABAergic targets within the
AHA (Figs. 7L and S7A–H). These AHA target neurons innervate the PVN, a structure that
regulates CORT release. Our experiments implicate LS Crfr2α+ neurons in the regulation of
circulating glucocorticoids. To our knowledge, optogenetic manipulations of specific
neuronal subpopulations that lead to changes in corticosterone levels have not previously
been reported. However, whether this endocrinological effect explains the persistent
elevation of anxiety is unclear. Indeed, our observation that AHA targets of LS Crfr2α+
neurons also project to the PAG raises the possibility that the behavioral and
endocrinological influences of LS Crfr2α+ neuronal activity may be mediated by parallel
neural pathways, as demonstrated in the extended amygdala (LeDoux et al., 1988; Viviani et
al., 2011; Kim et al., 2013).
Our data do not exclude the possibility that some LS Crfr2α+ neurons also act intra-septally
to promote anxiety, for example by inhibiting anxiolytic LS subpopulations. The existence
of anxiolytic neurons is supported by the observation that excitotoxic LS lesions can
enhance stress-induced activation of the HPA axis (Singewald et al., 2011). LS neurons in
general are thought to send recurrent GABAergic collaterals that terminate on other neurons
throughout the LS (Sheehan et al., 2004). These data suggest that the level of stress-induced
anxiety may be controlled by a balance of activity between anxiogenic and anxiolytic LS
populations. It has recently been shown that the BNST contains distinct anxiogenic and
anxiolytic GABAergic neuronal subsets with unique patterns of long-range connections
(Jennings et al., 2013; Kim et al., 2013). Whether specific anxiolytic output neurons exist in
the LS, in addition to the anxiogenic outputs identified here, remains to be determined.
LS Crfr2α+ neurons can generate persistent states of anxiety
The time-resolved nature of optogenetic manipulations has revealed that transient activation
of LS Crfr2α+ neurons can induce anxiety that persists for at least half an hour following the
offset of photostimulation. Other optogenetic manipulations have revealed rapidly reversible
effects on anxiety. For example, photostimulation of excitatory basolateral amygdala
projections to central amygdala resulted in an acute anxiolytic effect that rapidly dissipated
upon cessation of stimulation (Tye et al., 2011). Similarly, optogenetic stimulation of
Drd1a+ neurons in the oval nucleus of BNST acutely but reversibly elevated anxiety (Kim et
al., 2013). In contrast, photostimulation of glutamatergic projections from ventral BNST to
the ventral tegmental area (VTA) (Jennings et al., 2013) was sufficient to induce a persistent
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elevation in anxiety. These results suggest that distinct pathways may be responsible for
controlling acute versus persistent anxiety. It is additionally interesting to note that the two
pathways thus far found to display persistence (vBNST-VTA and LS-AHA) are both
anxiogenic. It remains to be seen whether persistent anxiolytic pathways exist, or if
persistence is rather a unique property of circuits that elevate anxiety.
The present studies have identified a cellular point-of-entry to an important but understudied
node in the brain circuitry that regulates emotional responses to stress. Our results provide
further evidence of the importance of long-range GABAergic projection neurons in the
control of anxiety (Jennings et al., 2013; Kim et al., 2013). Future studies should reveal the
inputs to LS Crfr2+ neurons, the interactions of these neurons with other genetically and
functionally distinct LS subpopulations, and the functional relationship between the SHA
and the extended amygdala in the control of anxiety. Together such studies should provide a
neural circuit-level framework for understanding how genetic and environmental factors
shape an individual’s response to stress, and may identify new potential routes for
therapeutic intervention in anxiety disorders.
EXPERIMENTAL PROCEDURES
Generation of Crfr2α-eGFPCre BAC transgenic mice
A bacterial artificial chromosome (BAC clone RP23-78P13) containing the mouse Crfr2
gene was subjected to twp rounds of RecA-mediated homologous recombination to: 1)
disrupt expression of Inmt, a gene present on the BAC and known to be expressed in the
brain; and 2) insert an eGFPCre-SV40pA cassette at the start codon in the third exon of the
brain-selective alpha-splice variant of the Crfr2 gene. The final recombineered BAC was
linearized with NotI, purified using Sepharose CL4b, confirmed by pulsed field gel
electrophoresis, and then microinjected into the pronuclei of FVB/N embryos to generate
transgenic mice.
Animal maintenance
The Crfr2α-eGFPCre BAC transgene was maintained on an FVB/N (Taconic) background.
For behavior experiments, hemizygous transgenic FVB/N males were bred to nontransgenic
C57BL/6N (Harlan Sprague Dawley) females, and FVBB6F1 male transgenics used for
testing. Animals were housed at 23°C with ad libitum access to food and water in a 13-h
day/11-h night cycle, with the day starting at 21:00. Behavioral testing was done during the
dark cycle, starting no earlier than 11:00 and no later than 20:00. Following surgery, mice
were singly housed.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Research highlights
• Crfr2 defines a molecularly distinct subset of predominantly GABAergic LS
neurons
• Crfr2+ neuronal activation promotes, while inhibition suppresses, persistent
anxiety
• These anxiogenic effects are exerted in part via projections to medial
hypothalamus
• LS Crfr2+ outputs positively regulate circulating corticosteroid levels
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Figure 1. Circuit models for LS CRFR2+ neuronal regulation of anxiety
(A) Sagittal plane of LS anatomy showing simplified feedforward connections. (B) Coronal
section at plane indicated by dashed line in (A). Modified from Allen Brain Atlas
(www.brain-map.org). (C, D) Circuit models consistent with known anxiogenic effect of
CRFR2 agonists in the LS. Depending on whether agonists excite (C) or inhibit (D)
CRFR2+ (“R2”) neurons, increased R2 neuronal activity would be anxiogenic (C) or
anxiolytic (D). GABAergic R2 neurons (Fig. 2F) may be local interneurons (“IN;” C1, D3)
or projection neurons (“PN;” C2, D4). LS output may be anxiolytic (C1, D4) or anxiogenic
(C2, D3).
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Figure 2. Characterization and transgenic targeting of LS Crfr2α+ neurons
(A–E) Crfr2 mRNA ISH; coronal diagrams in (A) depict region analyzed.
(F) dFISH for Crfr2 (green) and Gad2 (red).
(G,H) dFISH for Crfr2 (green) vs Esr1 (red): Crfr2+/DAPI+ = 8.3%, Esr1+/DAPI+ = 1.7%,
Crfr2+/Esr1+ = 0, Esr1+/Crfr2+ = 0; total n = 11,086 DAPI+ cells
(I,J) dFISH for Crfr2 (green) vs Penk (red): Crfr2+/DAPI+ = 9.3%, Penk+/DAPI+ = 3.3%,
Crfr2+/Penk+ = 0.1%, Penk+/Crfr2+ = 0.4%; total n = 8,274 DAPI+ cells
(K) Crfr2α-eGFPCre BAC transgene design.
(L,M) dFISH, Cre mRNA (green) vs. Crfr2 mRNA (red): Crfr2+/DAPI+ = 9.3%, Cre+/
DAPI+ = 3.7%, Cre+/Crfr2+ = 34.4%, Crfr2+/Cre+ = 86.6%; total n = 17,537 DAPI+ cells
(N,O) eGFPCre+ nuclei (green) vs. UCN3 pericellular baskets (pcbs; red); counts from areas
with detectable transgene expression. UCN3+ pcbs colocalize with synaptophysin (data not
shown). eGFPCre+/DAPI+ = 12.8%, UCN3pcb+/DAPI+ = 11.8%, UCN3pcb+/eGFPCre+ =
65.2%, eGFPCre+/UCN3pcb+ = 71.0%; total n = 2,665 Nissl+ cells
(P) Injection site (left) and Cre-dependent AAV (right).
(Q,R) Transgenic eGFPCre+ nuclei (green) vs. recombined, viral tdT (red); counts from
areas containing tdT+ cells. eGFPCre+/DAPI+ = 11.7%, tdT+/DAPI+ = 6.3%, tdT+/
eGFPCre+ = 42.1%, eGFPCre+/tdT+ = 77.9%; total n = 3,586 DAPI+ cells
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(S,T) dFISH for Crfr2 mRNA (green) vs. tdT mRNA (red); counts from areas containing
tdT+ cells. Crfr2+/DAPI+ = 12.5%, tdT+/DAPI+ = 7.1%, tdT+/Crfr2+ = 51.9%, Crfr2+/tdT+
= 91.6%; total n = 5,829 DAPI+ cells
In this and subsequent figures, dashed lines at left indicate lateral ventricle (LV), boxed
regions shown at higher magnification in insets.
See also Figures S1 and S2.
Anthony et al. Page 16
Cell. Author manuscript; available in PMC 2015 January 30.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Figure 3. Optogenetic stimulation of LS Crfr2α+ neurons induces a persistent, anxious state
(A) Cre-dependent ChR2-YFP AAV.
(B–D) Injection of (A) into Crhr2α-eGFPCre LS yielded ChR2-YFP (green) in Cre+ cells
(red).
(E) Recombination specificity and sensitivity; counts done in areas containing ChR2-YFP+
cells: ChR2+/DAPI+ = 4.6±1.1%, Cre+/DAPI+ = 12.4±1.7%, Cre+/ChR2+=79.7±2.9%,
ChR2+/Cre+=29.0±2.1% (mean±s.e.m.). Total n = 9,673 DAPI+ cells from 2 mice.
(F) top, ChR2 activity in Crfr2α+ cells assessed in acute slices; bottom, patched YFP+
neuron under infrared differential interference contrast (IR-DIC) microscopy.
(G,H) Robust photocurrents were observed (G) that were sufficient to drive repetitive,
tetrodotoxin(TTX)-sensitive spiking in ChR2-YFP+ neurons (H).
(I,J) Surgical manipulations and behavioral testing.
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(K) Photostimulation of Crfr2α+ neurons during behavioral testing increased anxiety.
hrGFP(n=39) vs. ChR2(n=38): LDB, entries in light side (4.6±0.8 vs. 2.5±0.6, P<0.05), time
in light side (58.6±11.4 vs. 21.0±7.6, P<0.01); OF, entries in center (11.0±1.2 vs 6.4±0.9,
P<0.01), time in center (17.9±2.1 vs. 8.5±1.2, P<0.001); NO, entries in center (21.0±2.6 vs.
13.6±2.0, P<0.05), time in center (44.7±6.8 vs. 24.9±5.1, P<0.05). P values represent two-
tailed unpaired t-tests. Values indicate mean±s.e.m.
(L) Photostimulation of Crfr2α+ neurons increased anxiety during subsequent testing.
eYFP(n=13) vs. ChR2(n=12): LDB, entries in light side (15.2±1.7 vs. 7.6±1.4, P<0.01),
time in light side (180.2±24.8 vs. 98.0±20.1, P<0.05); OF(0–5′), entries in center (12.2±1.8
vs. 6.3±1.0, P<0.01), time in center (16.3±2.4 vs. 9.2±2.3, P<0.01); NO(0–5′), entries in
center (21.7±2.8 vs. 13.0±2.0, P<0.05), time in center (55.4±8.7 vs. 25.3±5.0, P<0.01).
(M) Stimulating Crfr2α+ neurons exacerbates the anxiogenic effects of IMS (mice were
habituated to minimize ceiling effect confound, see methods). hrGFP (n=7) vs. ChR2 (n=8),
data presented as Mann-Whitney U value, P value: LDB, entries in light side (U = 7.5,
P<0.05), time in light side (U = 10.5, P<0.05); OF, entries in center (U = 15.5, P>0.15),
time in center (U = 22.5, P>0.55); NO, entries in center (U = 7.0, P<0.05), time in center (U
= 10.0, P<0.05).
(N) Model of LS Crfr2α+ neuronal valence based on optogenetic stimulation.
See also Figure S3.
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Figure 4. LS Crfr2α+ neurons are necessary for the induction and expression of a stress-induced,
anxiogenic state
(A) Cre-dependent eNpHR(2.0)-YFP AAV.
(B–D) Injection of (A) into Crhr2α-eGFPCre LS yielded eNpHR-YFP (green) in Cre+ cells
(red).
(E) Recombination specificity and sensitivity; counts from areas containing eNpHR-YFP+
cells: eNpHR+/DAPI+ = 4.7±0.2%, Cre+/DAPI+ = 11.4±0.4%, Cre+/eNpHR+=71.2±1.6%,
eNpHR+/Cre+=29.8±3.0% (mean±s.e.m.). Total n = 8,216 DAPI+ cells from 2 mice.
(F–H) Recordings from eNpHR-YFP+Crfr2α+ neurons. (G) Cell in response to the same
current injections in absence (top) or presence (bottom) of 593nm light. (H) 593nm light
significantly suppressed firing of eNpHR-YFP+ neurons (F1,108 = 28.69, P<0.001).
(I,J) Surgical manipulations and behavioral testing.
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(K) Photoinhibition of Crfr2α+ neurons only during IMS reduced anxiety in subsequent
testing. hrGFP (n=15) vs. eNpHR (n=17), data presented Mann-Whitney U value, P value:
LDB, entries in light side (U = 64.0, P<0.05), time in light side (U = 62.5, P<0.05); OF,
entries in center (U = 69.0, P<0.05), time in center (U = 64.5, P<0.05); NO, entries in center
(U = 73.5, P<0.05), time in center (U = 34.0, P<0.001).
(L) IMS mice that received photoinhibition of Crfr2α+ neurons only during behavioral
testing showed reduced anxiety relative to controls. hrGFP (n=11) vs. eNpHR (n=11): LDB,
entries in light side (U = 21.5, P<0.01), time in light side (U = 20.0, P<0.01); OF, entries in
center (U = 25.5, P=0.07), time in center (U = 23.0, P<0.05); NO, entries in center (U =
22.0, P<0.05), time in center (U = 21.0, P<0.05).
(M) Inhibiting Crfr2α+ neurons in the absence of IMS does not alter anxiety. hrGFP(n=11)
vs. eNpHR (n=11): LDB, entries in light side (11.5±1.9 vs. 11.7±2.3, P>0.9), time in light
side (218.7±44.6 vs. 206.4±45.2, P>0.8); OF, entries in center (23.1±2.6 vs. 20.4±2.8,
P>0.45), time in center (34.4±3.2 vs. 26.7±4.4, P>0.15); NO, entries in center (43.0±6.3 vs.
39.0±3.9, P>0.6), time in center (97.0±15.8 vs. 97.5±14.9, P>0.95).
(N) Model for LS Crfr2α+ neuronal valence based on optogenetic inhibition.
See also Figure S4.
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Figure 5. LS Crfr2α+ neurons make GABAergic synapses in the AHA
(A–G) Cre-dependent ChR2-YFP AAV injected into Crfr2α-eGFPCre LS labeled cell
bodies (arrowhead in B, enlarged in C) and axons (arrow in B, enlarged in D) Terminals
were densest in AHA (E). All AHA labeling was axonal (F, enlarged from boxed area in E).
YFP+ axons appeared to be excluded from the PVN (G). ac, anterior commissure; f, fornix;
PVN, paraventricular hypothalamic nucleus.
(H–O) CTB retrograde tracing. eGFPCre (green) and CTB (red) in the LS of Crfr2α-
eGFPCre mice that received iontophoretic injection of CTB into the AHA (I,J) or LH (M,N).
(K) A significant fraction of Crfr2α+ neurons project to AHA (CTB+/DAPI+ = 4.3±0.7% vs.
CTB+/eGFPCre+ = 33.0±1.0%, P<0.001), and Crfr2α+ neurons comprise a large fraction of
the neurons that project to AHA from middle levels of LS (GFPCre+/DAPI+ = 5.5±1.1% vs.
eGFPCre+/CTB+ = 42.0±3.1%, P<0.001). (O) Few Crfr2α+ neurons innervate the LH
(CTB+/DAPI+ = 3.8±0.01% vs. CTB+/eGFPCre+ = 1.8±0.1%, P<0.01), with most
projections to this region coming from Crfr2α− cells (GFPCre+/DAPI+ = 5.9±0.4% vs.
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eGFPCre+/CTB+ = 2.8±0.1%, P<0.05). Counts done at bregma+0.6 in LS regions that
contained CTB+ cells. Total n = 7,737 DAPI+ cells (AHA) and n = 5,767 DAPI+ cells (LH).
Values indicate mean±s.e.m.
(P,Q) CRACM in standard ACSF or plus 100μM picrotoxin (PTX). (Q) Single 2ms pulses
of 473nm light evoked IPSCs blocked by PTX (top). Inset, higher temporal resolution to
illustrate response latency. (bottom), picrotoxin-sensitive inhibition of spontaneous firing
observed by presynaptic terminal photostimulation (15Hz, 2ms pulses).
See also Figure S5.
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Figure 6. LS Crfr2α+ projections to AHA are necessary for stress-induced anxiety
(A) Cre-dependent ArchT-GFP AAV.
(B–E) Axon terminal inhibition. (C,D) ArchT-GFP in LS Crfr2α+ (C) cell bodies and (D)
and axons in AHA. (E) Photoinhibition of Crfr2α+ axon terminals in AHA during
behavioral testing in IMS-stressed mice reduces anxiety. hrGFP (n=10) vs. ArchT (n=12),
data presented Mann-Whitney U value, P value: LDB, entries in light side (U = 25.0,
P<0.05), time in light side (U = 24.0, P<0.05); OF(5–10′), entries in center (U = 21.5,
P<0.05), time in center (U = 26.0, P<0.05); NO(0–5′), entries in center (U = 29.5, P<0.05),
time in center (U = 19.0, P<0.05).
(F) Cre-dependent ChR2-YFP AAV.
(G–J) Axon terminal stimulation. (H,I) ChR2-YFP in LS Crfr2α+ (H) cell bodies and (I)
axons. (J) Stimulation of Crfr2α+ axon terminals in AHA during testing increased anxiety.
eYFP(n=17) vs. ChR2(n=15): LDB, entries in light side (5.2±1.6 vs. 2.5±0.4, P>0.1), time
in light side (79.9±23.2 vs. 20.3±4.6, P<0.05); OF, entries in center (15.1±2.3 vs. 7.4±1.3,
P<0.01), time in center (26.8±4.2 vs. 9.5±1.8, P<0.01); NO, entries in center (32.9±5.0 vs.
22.5±2.9, P=0.08), time in center (77.2±15.2 vs. 74.9±18.3, P>0.1); values indicate mean
±s.e.m. P values represent two-tailed unpaired t-tests.
Dashed lines in (D,I) indicate guide tips.
See also Figure S6.
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Figure 7. LS Crfr2α+ projections to AHA are polysynaptically upstream of PVN and positively
regulate corticosterone levels
(A,A′) HSV129ΔTK-TT.
(B–D) tdT (red) in HSV129ΔTK-TT-injected Crfr2α-eGFPCre mice counterstained with
DAPI (blue) at 1 (B) or 3 (C,D) days post-injection (dpi) in LS (B,C) or medial
hypothalamus (D). Dashed lines in (D) demarcate PVN (upper right) and AHA (lower left).
(E–G) Combined CRACM and retrograde tracing. (F) A slice used for recording;
Crfr2α+ChR2-YFP+ axons originating from LS (green), retrobeads (red), and two
neurobiotin-filled neurons (blue). The cell that yielded the traces in (G) is shown at higher
magnification in the inset. (G) A 2ms pulse of 473nm light induced monosynaptic IPSCs in
4/9 retrobead+ AHA neurons that were sufficient to inhibit firing (G′).
(H,I) Optogenetic stimulation of LS Crfr2α+ neurons increased CORT. eYFP(n=9) vs.
ChR2(n=9): CORT, ng/ml (159.2±9.3 vs. 228.8±30.9, P<0.05).
(J,K) Optogenetic inhibition of LS Crfr2α+ projections to AHA decreased CORT.
hrGFP(n=15) vs. ArchT-GFP(n=17): CORT, ng/ml (162.1±8.6 vs. 134.5±4.1, P<0.01).
Values indicate mean±s.e.m.
(L) Proposed model for LS Crfr2α+ neuronal control of stress-induced anxiety.
See also Figure S7.
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